Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
about
Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic StrokeAnti-inflammatory therapy in chronic disease: challenges and opportunitiesTargeting interleukin-1 in heart diseaseCholesterol crystals and inflammationCXCL5 limits macrophage foam cell formation in atherosclerosisSmooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective.KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.Recent insights into the cellular biology of atherosclerosisDetection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysmsCigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular diseaseSmooth muscle cell phenotypic switching in atherosclerosisThe addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study.Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.Inflammation and its resolution as determinants of acute coronary syndromes.Moderate hypoxia potentiates interleukin-1β production in activated human macrophages.Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.Bone marrow deficiency of MCPIP1 results in severe multi-organ inflammation but diminishes atherogenesis in hyperlipidemic mice.Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.IL-1 and atherosclerosis: a murine twist to an evolving human story.Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease.Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial RemodelingCytokines: roles in atherosclerosis disease progression and potential therapeutic targetsCardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysisIL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1βInterleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease.Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma.Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null miceA Systems Biology Approach to Characterize Biomarkers for Blood Stasis Syndrome of Unstable Angina Patients by Integrating MicroRNA and Messenger RNA Expression ProfilingCD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop.Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.Interleukins and atherosclerosis: a dysfunctional family grows.Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosisTh17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice.
P2860
Q26765807-A5DE4F41-F3B8-41E8-AF0A-2149B153D6FCQ26860162-56FE8B78-1777-403D-8EE2-A53BB3D58C4DQ27009347-F50A9EE5-6273-4DEC-B5E5-826CEC1F4FC0Q27024737-982881F6-3F9C-4BB5-B704-AC1FB51F14F3Q28284807-7BD49452-D860-4927-96FD-17C352836648Q30252988-B2117011-5C8E-4A1A-B435-6E9E4B0C1485Q30276803-70BE7696-9B61-4911-8591-E3A2780D0141Q30299921-C5B7287B-B7B2-4525-A71E-902BC0CC8AC1Q30300194-534F6A61-56A1-4F4A-8475-5C2B4FB17246Q30408017-B6C6C332-3074-40A4-BCEA-74BCAF5BC068Q30412759-F4979A04-AE8C-4F5A-927F-1F5A2A48E83BQ30417628-C2981F92-5E9C-4E3F-AABC-C711F1AF8576Q30418243-DAFE956C-52F9-4F4C-8241-869B161DB329Q33716972-FE453E69-6BAF-4DBE-B010-25ABD76CA996Q33804422-874209B0-CEA7-4DFE-BA63-3429BF28BD49Q33834800-435B9372-D1F2-423F-8351-971B6FAEFF45Q34403101-E4F5D6D1-6712-4F7A-867A-FEF0A9F51764Q34985696-B51B623A-05A4-4A94-B24F-9F45D40E88B5Q35040388-AD54998F-59DE-4909-8482-32DB30530B9BQ35148920-A9E40CA1-8845-4F7E-B850-66C011F143FFQ35640438-784D5EDC-0E39-407B-BF44-7CE5709ECDFFQ35640654-AA31FFF3-479C-4748-B6CF-38F7AFA42578Q35670584-BB5583CE-3D80-4125-AE58-ADC4FB2E0BB6Q35888047-B65D9CAD-28B6-40EA-BB83-B5D173D2422DQ35941258-C8B65C82-099F-4C82-B258-36C43AA97BF3Q35975645-4AD590E9-268B-4090-9F6F-467150DE6517Q36064353-6F1FDE12-F198-4ECA-8AD0-86E09E077F09Q36287541-B8B006B3-625B-475D-AE29-7EA453C8CF94Q36326783-CA92DBE6-97C7-436F-8391-FE841C9A49AAQ36374549-2F14B421-7B64-425F-AB5D-660DD2D5F29AQ36624292-C24D868C-C715-469C-9FBA-54408252025DQ36807912-E7B16A38-BA2D-4044-AD1E-B45CEC01484EQ36883314-8650003F-F204-416C-9763-F63CFE991180Q37165792-1FA58108-1B74-4369-9531-1819A2247A5EQ37281999-5C701AE7-77B8-4B09-8D1A-056BF8F92D25Q37338935-BE5FD290-D172-4EEF-95A7-5661C721BC63Q37407167-D26FCCF4-7765-426E-BAEA-2BE33C9E7013Q37572983-3F326301-18B2-4D29-8199-86375BBCA0CBQ37609624-AF7A7865-E3CE-44C6-B7D1-0E1A130EE5B8Q37729656-3853F023-B1B5-444A-9178-E9CE14C935D3
P2860
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@ast
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@en
type
label
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@ast
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@en
prefLabel
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@ast
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@en
P2093
P2860
P356
P1476
Genetic inactivation of IL-1 s ...... vanced atherosclerosis in mice
@en
P2093
Christopher L Jackson
Christopher W Moehle
Gary K Owens
Matthew R Alexander
Zhengyu Yang
P2860
P356
10.1172/JCI43713
P407
P577
2011-12-27T00:00:00Z